fda glp-1 enforcement news says that the shortage is over FDA issued 30 warning letters
Description
There is no known clinically significant pharmacokinetic interaction between semaglutide and amphetamine-based ADHD medications

OXM shows better weight loss, lipid-lowering, and blood sugar control than GLP-1R agonists
Science Translational Medicine 5209ra151
At the same time, in 2002, Gipr knockout mice were found to be protected against both obesity and insulin resistance induced by high-fat feeding (53)

When total food intake falls significantly, it becomes easy to fall short on vitamins and minerals that support muscle function
